Venture into the DKNY Delicious Night
This article was originally published in The Rose Sheet
Executive Summary
Estee Lauder will promote DKNY Delicious Night fragrance with 1www.UncoverTheCity.com, a site designed to evoke "the energy, ethos and spirit of NYC at night," the firm says. The website will go live on Oct. 1. Visitors are invited to venture into the city that never sleeps and tour the city's clubs, restaurants, shops and music as well as view behind-the-scenes footage of the DKNY Delicious Night commercial. Lauder also is promoting its Mustang scent for men online (2"The Rose Sheet" Sept. 24, 2007, p. 2)...
You may also be interested in...
Marketing In Brief
LovelySkin: Skin-care company founded by dermatologist Joel Schlessinger, M.D., president of the American Society of Cosmetic Dermatology and Aesthetic Surgery, announces launch of FixMySkin line "aimed at men with skin-care concerns such as acne and poor skin texture." Schlessinger states: "I have long known that men are the underserved in the skin world. While products abound for women, men oftentimes don't 'connect' with products due to inappropriate fragrances or labeling." FixMySkin products are scent-free and formulated with lower pH levels than most products on the market, pH levels of which range from 3.8 and upward, "which doesn't allow for much exfoliation," according to LovelySkin. Company also is introducing LovelySkin Gel Cleanser for individuals with oily skin, which will join its other products containing amino fruit acids and "wrinkle-fighting" vitamin C to "soothe and hydrate skin while combating the signs of aging." Company's Web site also offers for purchase products "typically available only in a dermatologist or cosmetic surgeon's office" from brands such as Obagi, Peter Thomas Roth, Dr. Brandt, SkinMedica, SkinCeuticals, Murad, LaRoche-Posey, theBalm and RevaleSkin...
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.
US FDA Expects Joint AdComm Briefing Document, Oncology Chief Says
The combined format is the new default for briefing advisory committee members, US FDA Oncology Center of Excellence Director Pazdur declared.